gms | German Medical Science

102. Jahrestagung der DOG

Deutsche Ophthalmologische Gesellschaft e. V.

23. bis 26.09.2004, Berlin

OCT findings of a chronically central serous retinopathy (CSR) combined with a pigment-epithelium detachment (PED) pre and post selective-RPE-Laser-Treatment (SRT) – a case report

Meeting Abstract

  • corresponding author C. Klatt - Ophthalmology, Universitätsklinikum Schleswig Holstein, Campus Kiel
  • A. Bunse - Ophthalmology, Universitätsklinikum Schleswig Holstein, Campus Kiel
  • H. Elsner - Ophthalmology, Universitätsklinikum Schleswig Holstein, Campus Luebeck
  • E. Pörksen - Ophthalmology, Universitätsklinikum Schleswig Holstein, Campus Luebeck
  • R. Birngruber - Medizinisches Laserzentrum Lübeck
  • J. Roider - Ophthalmology, Universitätsklinikum Schleswig Holstein, Campus Kiel

Evidenzbasierte Medizin - Anspruch und Wirklichkeit. 102. Jahrestagung der Deutschen Ophthalmologischen Gesellschaft. Berlin, 23.-26.09.2004. Düsseldorf, Köln: German Medical Science; 2004. Doc04dogP 149

The electronic version of this article is the complete one and can be found online at:

Published: September 22, 2004

© 2004 Klatt et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.




Clinical findings in chronically central serous retinopathy (CSR) are variable and difficult to handle. We present a patient 52 years of age with chronical subfoveal and parafoveal leckage in fluorescein angiography (FA) without spontaneous improvement for two years. The OCT (OCT III, Humphrey/Zeiss) displayed a subfoveal detachment of the pigmentepithelium (PED) in combination with an accumulation of subretinal serous fluid.


Initially the patient had a visual acuity of 0,63. A confluent focal photocoagulation of the leckage area and the pigment epithelium detachment (PED) was performed by Selective-RPE-Laser-Treatment (SRT). Selective-RPE-Laser-Treatment (SRT) uses a frequency doubled Q-switched Nd:YLF Lasers (527 nm). Each laser exposition applies a train of 30 pulses, each of 1,7 μs duration, at a repetition rate of 100 Hz. The spotsize is 120 μm. SRT selectively damages RPR cells while sparing retinal structures.


Post SRT subretinal serous fluid resorbed completely within 10 weeks. In spite of confluent Selective-RPE-Laser-Treatment (SRT) visual acuity remained the same (V=0,63). The pigment epithelium detachment (PED) remained unaffected, in particular there was no RIP-Syndrom observed.


Due to its selectivity it seems possible to treat pathological retina findings by Selective-RPE-Laser-Treatment (SRT) associated with pigmentepithelium detachment (PED) without causing residual damage effectively.